INCYTE CORPORATION Prepaid Expense and Other Assets, Current
INCYTE CORPORATION (INCY) had Prepaid Expense and Other Assets, Current of $301.31 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-04-28
- 2026-03-31: Prepaid Expense and Other Assets, Current $301.31M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $317.83M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $368.73M.
- 2025-06-30: Prepaid Expense and Other Assets, Current $295.65M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-03-31 | $301.31M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $317.83M 10-Q · filed 2026-04-28 | |
| 2025-09-30 | $368.73M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $295.65M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $211.65M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $168.91M 10-K · filed 2026-02-10 | |
| 2024-09-30 | $205.13M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $207.96M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $189.24M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $182.83M 10-K · filed 2025-02-10 | |
| 2023-09-30 | $171.75M 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $167.14M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $194.26M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $167.01M 10-K · filed 2024-02-13 | |
| 2022-09-30 | $179.93M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $165.95M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $146.13M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $126.28M 10-K · filed 2023-02-07 | |
| 2021-09-30 | $101.73M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $84.25M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $73.52M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $60.10M 10-K · filed 2022-02-08 | |
| 2020-09-30 | $51.43M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $51.55M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $48.08M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $43.73M 10-K · filed 2021-02-09 | |
| 2019-09-30 | $49.90M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $53.56M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $72.27M 10-Q · filed 2019-04-30 | |
| 2018-12-31 | $79.37M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $71.32M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $77.52M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $73.67M 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $62.43M 10-K · filed 2019-02-14 | |
| 2017-09-30 | $58.33M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $63.75M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $58.28M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $32.77M 10-K · filed 2018-02-15 | $32.75M 10-K · filed 2017-02-14 |
| 2016-09-30 | $34.46M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $27.31M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $21.81M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $17.84M 10-K · filed 2017-02-14 | |
| 2015-09-30 | $23.25M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $20.26M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $28.18M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $20.52M 10-K · filed 2016-02-12 | |
| 2014-09-30 | $18.98M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $19.27M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $13.68M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $9.62M 10-K · filed 2015-02-17 | |
| 2013-09-30 | $9.01M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $8.26M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $10.70M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $9.87M 10-K · filed 2014-02-21 | |
| 2012-09-30 | $8.90M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $8.82M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $7.45M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $7.47M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $7.98M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $6.45M 10-Q · filed 2011-07-28 | |
| 2010-12-31 | $6.60M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |